References
- Kreutz M, Tacken PJ, Figdor CG. Targeting dendritic cells--why bother?. Blood 2013; 121:2836 - 44; http://dx.doi.org/10.1182/blood-2012-09-452078; PMID: 23390195
- Mescher MF, Curtsinger JM, Agarwal P, Casey KA, Gerner M, Hammerbeck CD, Popescu F, Xiao Z. Signals required for programming effector and memory development by CD8+ T cells. Immunol Rev 2006; 211:81 - 92; http://dx.doi.org/10.1111/j.0105-2896.2006.00382.x; PMID: 16824119
- Agarwal P, Raghavan A, Nandiwada SL, Curtsinger JM, Bohjanen PR, Mueller DL, Mescher MF. Gene regulation and chromatin remodeling by IL-12 and type I IFN in programming for CD8 T cell effector function and memory. J Immunol 2009; 183:1695 - 704; http://dx.doi.org/10.4049/jimmunol.0900592; PMID: 19592655
- Banerjee A, Gordon SM, Intlekofer AM, Paley MA, Mooney EC, Lindsten T, Wherry EJ, Reiner SL. Cutting edge: The transcription factor eomesodermin enables CD8+ T cells to compete for the memory cell niche. J Immunol 2010; 185:4988 - 92; http://dx.doi.org/10.4049/jimmunol.1002042; PMID: 20935204
- Carreno BM, Becker-Hapak M, Huang A, Chan M, Alyasiry A, Lie WR, Aft RL, Cornelius LA, Trinkaus KM, Linette GP. IL-12p70-producing patient DC vaccine elicits Tc1-polarized immunity. J Clin Invest 2013; 123:3383 - 94; http://dx.doi.org/10.1172/JCI68395; PMID: 23867552
- Gerner MY, Heltemes-Harris LM, Fife BT, Mescher MF. Cutting edge: IL-12 and type I IFN differentially program CD8 T cells for programmed death 1 re-expression levels and tumor control. J Immunol 2013; 191:1011 - 5; http://dx.doi.org/10.4049/jimmunol.1300652; PMID: 23804712
- Nizzoli G, Krietsch J, Weick A, Steinfelder S, Facciotti F, Gruarin P, Bianco A, Steckel B, Moro M, Crosti M, et al. Human CD1c+ dendritic cells secrete high levels of IL-12 and potently prime cytotoxic T-cell responses. Blood 2013; 122:932 - 42; http://dx.doi.org/10.1182/blood-2013-04-495424; PMID: 23794066